abstract |
The invention encompasses compositions comprising IL-33 specific binding polypeptides and IL-33 specific binding polypeptides, such as antibodies and monomer / multimer domain polypeptides. The invention also encompasses methods of using IL-33 specific binding polypeptides to treat diseases and disorders such as asthma. |